Avantor Inc.. (AVTR) NEW YORK STOCK EXCHANGE INC.
$24.38 (0.22) (-0.89%)
Market Cap: $16.69B
As of 04/17/24 04:00 PM EDT. Market closed.
Avantor Inc.. (AVTR)
NEW YORK STOCK EXCHANGE INC.
$24.38
(0.22) (-0.89%)
Market Cap: $16.69B
As of 04/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical ... read more
based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. our electronics solutions are used in the manufacturing of semiconductors. for additional information please visit www.avantormaterials.com read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
Full Time Employees
4,465
Address
.
PRICE CHART FOR AVANTOR INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$24.66
Previous Close
$24.60
Days Range
$24.41 - $24.79
52 week range
$16.63 - $26.11
Volume
5,696,340
Avg. Volume (30 days)
3,711,258
Market Cap
$16.69B
Dividend Yield
-
P/E
51.96
Shares Outstanding
678,281,383
Open
$24.66
Previous Close
$24.60
Days Range
$24.41 - $24.79
52 week range
$16.63 - $26.11
Volume
5,696,340
Avg. Volume (30 days)
3,711,258
Market Cap
$16.69B
Dividend Yield
-
P/E
51.96
Shares Outstanding
678,281,383
FINANCIAL STATEMENTS FOR AVANTOR INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR AVANTOR INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Couturier Christophe | EVP, AMEA | Apr 05, 2024 | Option Exercise | $25.87 | 569 | 14,720 | 83,320 | Apr 08, 2024, 05:05 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Mar 08, 2024 | Sale | $25.63 | 3,685 | 94,447 | 34,406 | Mar 12, 2024, 04:46 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 29, 2024 | Sale | $24.52 | 4,910 | 120,393 | 96,233 | Mar 01, 2024, 04:46 PM |
| Couturier Christophe | EVP, AMEA | Feb 29, 2024 | Sale | $24.53 | 13,074 | 320,705 | 83,889 | Mar 01, 2024, 04:42 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 27, 2024 | Sale | $24.49 | 6,203 | 151,911 | 101,143 | Feb 27, 2024, 05:02 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 25, 2024 | Option Exercise | $24.35 | 505 | 12,297 | 26,387 | Feb 26, 2024, 06:57 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 24, 2024 | Option Exercise | $24.35 | 438 | 10,665 | 26,892 | Feb 26, 2024, 06:57 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 23, 2024 | Option Exercise | $24.35 | 422 | 10,276 | 27,330 | Feb 26, 2024, 06:57 PM |
| Stubblefield Michael | President & CEO | Feb 22, 2024 | Option Exercise | $24.59 | 41,177 | 1,012,542 | 1,136,453 | Feb 26, 2024, 06:56 PM |
| Stubblefield Michael | President & CEO | Feb 25, 2024 | Option Exercise | $24.35 | 7,685 | 187,130 | 1,111,751 | Feb 26, 2024, 06:56 PM |
| Stubblefield Michael | President & CEO | Feb 24, 2024 | Option Exercise | $24.35 | 9,595 | 233,638 | 1,119,436 | Feb 26, 2024, 06:56 PM |
| Stubblefield Michael | President & CEO | Feb 23, 2024 | Option Exercise | $24.35 | 7,422 | 180,726 | 1,129,031 | Feb 26, 2024, 06:56 PM |
| Sahin Kitty | EVP, Strategy&Corp Development | Feb 24, 2024 | Option Exercise | $24.35 | 1,059 | 25,787 | 33,885 | Feb 26, 2024, 06:56 PM |
| Hankamer Brittany | EVP, Chief HR Officer | Feb 23, 2024 | Option Exercise | $24.35 | 421 | 10,251 | 24,479 | Feb 26, 2024, 06:56 PM |
| Hankamer Brittany | EVP, Chief HR Officer | Feb 25, 2024 | Option Exercise | $24.35 | 369 | 8,985 | 23,673 | Feb 26, 2024, 06:56 PM |
| Hankamer Brittany | EVP, Chief HR Officer | Feb 24, 2024 | Option Exercise | $24.35 | 437 | 10,641 | 24,042 | Feb 26, 2024, 06:56 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 25, 2024 | Option Exercise | $24.35 | 511 | 12,443 | 86,813 | Feb 26, 2024, 06:55 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 24, 2024 | Option Exercise | $24.35 | 1,955 | 47,604 | 87,324 | Feb 26, 2024, 06:55 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 23, 2024 | Option Exercise | $24.35 | 569 | 13,855 | 89,279 | Feb 26, 2024, 06:55 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 22, 2024 | Option Exercise | $24.59 | 2,842 | 69,885 | 89,848 | Feb 26, 2024, 06:55 PM |
| Couturier Christophe | EVP, AMEA | Feb 25, 2024 | Option Exercise | $24.35 | 467 | 11,371 | 87,723 | Feb 26, 2024, 06:55 PM |
| Couturier Christophe | EVP, AMEA | Feb 24, 2024 | Option Exercise | $24.35 | 648 | 15,779 | 88,190 | Feb 26, 2024, 06:55 PM |
| Couturier Christophe | EVP, AMEA | Feb 23, 2024 | Option Exercise | $24.35 | 416 | 10,130 | 88,838 | Feb 26, 2024, 06:55 PM |
| Couturier Christophe | EVP, AMEA | Feb 22, 2024 | Option Exercise | $24.59 | 2,574 | 63,295 | 89,254 | Feb 26, 2024, 06:55 PM |
| Hankamer Brittany | EVP, Chief HR Officer | Feb 20, 2024 | Option Exercise | $24.05 | 289 | 6,950 | 24,900 | Feb 22, 2024, 05:04 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 20, 2024 | Option Exercise | $24.05 | 1,216 | 29,245 | 85,258 | Feb 22, 2024, 05:04 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 20, 2024 | Option Exercise | $24.05 | 435 | 10,462 | 27,752 | Feb 22, 2024, 05:03 PM |
| Stubblefield Michael | President & CEO | Feb 20, 2024 | Option Exercise | $24.05 | 9,711 | 233,550 | 1,078,555 | Feb 22, 2024, 05:03 PM |
| Couturier Christophe | EVP, AMEA | Feb 20, 2024 | Option Exercise | $24.05 | 1,392 | 33,478 | 82,538 | Feb 22, 2024, 05:02 PM |
| Sahin Kitty | EVP, Strategy&Corp Development | Jul 18, 2023 | Option Exercise | $21.01 | 3,931 | 82,590 | 34,944 | Nov 29, 2023, 06:11 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Sep 07, 2023 | Sale | $20.64 | 7,577 | 156,389 | 28,187 | Sep 07, 2023, 05:01 PM |
| Hankamer Brittany | EVP, Chief HR Officer | Sep 05, 2023 | Option Exercise | $21.70 | 309 | 6,705 | 25,189 | Sep 05, 2023, 04:58 PM |
| Vanderhaegen Frederic | EVP, Americas and Europe | Aug 25, 2023 | Sale | $21.47 | 25,000 | 536,750 | 160,735 | Aug 28, 2023, 04:10 PM |
| Couturier Christophe | EVP, AMEA | May 17, 2023 | Option Exercise | $20.28 | 15,706 | 318,518 | 82,944 | May 19, 2023, 04:20 PM |
| Miller Justin | EVP & General Counsel | May 17, 2023 | Option Exercise | $20.28 | 12,449 | 252,466 | 93,336 | May 19, 2023, 04:20 PM |
| Stubblefield Michael | President & CEO | May 17, 2023 | Option Exercise | $20.28 | 106,200 | 2,153,736 | 1,172,937 | May 19, 2023, 04:20 PM |
| Brophy Gerard | EVP, Biopharma Production | May 17, 2023 | Option Exercise | $20.28 | 19,683 | 399,171 | 89,032 | May 19, 2023, 04:19 PM |
| Eck Steven W | SVP & Chief Accounting Officer | May 17, 2023 | Option Exercise | $20.28 | 553 | 11,215 | 21,180 | May 19, 2023, 04:19 PM |
| Vanderhaegen Frederic | EVP, Americas and Europe | May 17, 2023 | Option Exercise | $20.28 | 2,210 | 44,819 | 185,735 | May 19, 2023, 04:18 PM |
| Szlosek Thomas A | EVP & CFO | May 17, 2023 | Option Exercise | $20.28 | 23,261 | 471,733 | 77,489 | May 19, 2023, 04:18 PM |
| Bramwell James | EVP, Strategic Partners | May 17, 2023 | Option Exercise | $20.28 | 18,917 | 383,637 | 85,393 | May 19, 2023, 04:17 PM |
| Couturier Christophe | EVP, AMEA | Apr 11, 2023 | Sale | $21.18 | 1,498 | 31,728 | 98,650 | Apr 13, 2023, 05:03 PM |
| Couturier Christophe | EVP, AMEA | Apr 05, 2023 | Option Exercise | $20.82 | 569 | 11,847 | 100,148 | Apr 06, 2023, 04:38 PM |
| Brophy Gerard | EVP, Biopharma Production | Mar 03, 2023 | Sale | $25.00 | 3,914 | 97,850 | 108,715 | Mar 06, 2023, 04:38 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 27, 2023 | Sale | $25.00 | 3,059 | 76,475 | 112,629 | Mar 01, 2023, 04:46 PM |
| Couturier Christophe | EVP, AMEA | Feb 28, 2023 | Sale | $24.32 | 2,324 | 56,520 | 100,717 | Mar 01, 2023, 04:44 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 25, 2023 | Option Exercise | $24.62 | 2,040 | 50,225 | 115,688 | Feb 27, 2023, 08:10 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 23, 2023 | Option Exercise | $24.59 | 1,893 | 46,549 | 97,420 | Feb 27, 2023, 08:10 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 23, 2023 | Option Exercise | $24.59 | 421 | 10,352 | 16,891 | Feb 27, 2023, 08:09 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 25, 2023 | Option Exercise | $24.62 | 505 | 12,433 | 21,733 | Feb 27, 2023, 08:09 PM |
| Szlosek Thomas A | EVP & CFO | Feb 25, 2023 | Option Exercise | $24.62 | 2,040 | 50,225 | 104,853 | Feb 27, 2023, 08:09 PM |
| Szlosek Thomas A | EVP & CFO | Feb 23, 2023 | Option Exercise | $24.59 | 2,082 | 51,196 | 88,790 | Feb 27, 2023, 08:09 PM |
| Vanderhaegen Frederic | EVP, Americas and Europe | Feb 23, 2023 | Option Exercise | $24.59 | 213 | 5,238 | 167,936 | Feb 27, 2023, 08:09 PM |
| Vanderhaegen Frederic | EVP, Americas and Europe | Feb 25, 2023 | Option Exercise | $24.62 | 299 | 7,361 | 187,945 | Feb 27, 2023, 08:09 PM |
| Couturier Christophe | EVP, AMEA | Feb 25, 2023 | Option Exercise | $24.62 | 467 | 11,498 | 103,041 | Feb 27, 2023, 08:08 PM |
| Couturier Christophe | EVP, AMEA | Feb 23, 2023 | Option Exercise | $24.59 | 416 | 10,229 | 97,448 | Feb 27, 2023, 08:08 PM |
| Couturier Christophe | EVP, AMEA | Feb 23, 2023 | Sale | $24.24 | 3,078 | 74,611 | 94,370 | Feb 27, 2023, 08:08 PM |
| Henson Meghan | EVP, Chief HR Officer | Feb 25, 2023 | Option Exercise | $24.62 | 800 | 19,696 | 40,184 | Feb 27, 2023, 08:07 PM |
| Henson Meghan | EVP, Chief HR Officer | Feb 23, 2023 | Option Exercise | $24.59 | 816 | 20,065 | 28,799 | Feb 27, 2023, 08:07 PM |
| Bramwell James | EVP, Americas | Feb 23, 2023 | Option Exercise | $24.59 | 569 | 13,992 | 84,513 | Feb 27, 2023, 08:07 PM |
| Bramwell James | EVP, Americas | Feb 25, 2023 | Option Exercise | $24.62 | 511 | 12,581 | 104,310 | Feb 27, 2023, 08:07 PM |
| Miller Justin | EVP & General Counsel | Feb 25, 2023 | Option Exercise | $24.62 | 560 | 13,787 | 105,785 | Feb 27, 2023, 08:06 PM |
| Miller Justin | EVP & General Counsel | Feb 23, 2023 | Option Exercise | $24.59 | 468 | 11,508 | 97,207 | Feb 27, 2023, 08:06 PM |
| Lewis Sheri | EVP, Global Ops & Supply Chain | Feb 25, 2023 | Option Exercise | $24.62 | 1,340 | 32,991 | 75,248 | Feb 27, 2023, 08:05 PM |
| Lewis Sheri | EVP, Global Ops & Supply Chain | Feb 23, 2023 | Option Exercise | $24.59 | 970 | 23,852 | 64,403 | Feb 27, 2023, 08:05 PM |
| Stubblefield Michael | President & CEO | Feb 23, 2023 | Option Exercise | $24.59 | 7,422 | 182,507 | 1,187,818 | Feb 27, 2023, 08:05 PM |
| Stubblefield Michael | President & CEO | Feb 25, 2023 | Option Exercise | $24.62 | 7,685 | 189,205 | 1,279,137 | Feb 27, 2023, 08:05 PM |
| Szlosek Thomas A | EVP & CFO | Feb 20, 2023 | Option Exercise | $24.54 | 4,253 | 104,369 | 90,872 | Feb 22, 2023, 05:01 PM |
| Couturier Christophe | EVP, AMEA | Feb 20, 2023 | Option Exercise | $24.54 | 1,167 | 28,638 | 117,024 | Feb 22, 2023, 05:01 PM |
| Couturier Christophe | EVP, AMEA | Feb 22, 2023 | Sale | $24.12 | 19,160 | 462,139 | 97,160 | Feb 22, 2023, 05:01 PM |
| Miller Justin | EVP & General Counsel | Feb 20, 2023 | Option Exercise | $24.54 | 1,167 | 28,638 | 97,675 | Feb 22, 2023, 05:00 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 20, 2023 | Option Exercise | $24.54 | 435 | 10,675 | 17,312 | Feb 22, 2023, 04:59 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | Feb 20, 2023 | Option Exercise | $24.54 | 398 | 9,767 | 168,149 | Feb 22, 2023, 04:59 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 20, 2023 | Option Exercise | $24.54 | 3,072 | 75,387 | 99,313 | Feb 22, 2023, 04:58 PM |
| Bramwell James | EVP, Americas | Feb 20, 2023 | Option Exercise | $24.54 | 1,066 | 26,160 | 85,082 | Feb 22, 2023, 04:58 PM |
| Stubblefield Michael | President & CEO | Feb 20, 2023 | Option Exercise | $24.54 | 15,026 | 368,738 | 1,195,240 | Feb 22, 2023, 04:57 PM |
| Wondrasch Michael | EVP & CIO | Feb 20, 2023 | Option Exercise | $24.54 | 1,356 | 33,276 | 96,072 | Feb 22, 2023, 04:57 PM |
| Couturier Christophe | EVP, AMEA | Jan 31, 2023 | Option Exercise | $23.90 | 7,658 | 183,026 | 118,191 | Feb 02, 2023, 08:26 PM |
| Stubblefield Michael | CEO | Jan 31, 2023 | Option Exercise | $23.90 | 91,140 | 2,178,246 | 1,210,266 | Feb 02, 2023, 08:26 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 31, 2023 | Option Exercise | $23.90 | 15,221 | 363,782 | 113,724 | Feb 02, 2023, 08:25 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 02, 2023 | Sale | $25.06 | 11,339 | 284,155 | 102,385 | Feb 02, 2023, 08:25 PM |
| Miller Justin | EVP & General Counsel | Jan 31, 2023 | Option Exercise | $23.90 | 7,942 | 189,814 | 98,842 | Feb 02, 2023, 08:25 PM |
| Szlosek Thomas A | EVP & CFO | Jan 31, 2023 | Option Exercise | $23.90 | 24,187 | 578,069 | 124,574 | Feb 02, 2023, 08:25 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | Jan 31, 2023 | Option Exercise | $23.90 | 2,515 | 60,108 | 168,547 | Feb 02, 2023, 08:24 PM |
| Henson Meghan | EVP, Chief HR Officer | Dec 31, 2022 | Option Exercise | $21.09 | 1,790 | 37,751 | 29,615 | Jan 04, 2023, 04:59 PM |
| Lewis Sheri | EVP, Global Ops & Supply Chain | Dec 31, 2022 | Option Exercise | $21.09 | 6,075 | 128,122 | 65,373 | Jan 04, 2023, 04:59 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 02, 2023 | Option Exercise | $21.09 | 6,727 | 141,872 | 90,208 | Jan 04, 2023, 04:58 PM |
| Szlosek Thomas A | EVP & CFO | Jan 02, 2023 | Option Exercise | $21.09 | 8,313 | 175,321 | 109,395 | Jan 04, 2023, 04:57 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | Jan 02, 2023 | Option Exercise | $21.09 | 1,017 | 21,449 | 126,363 | Jan 04, 2023, 04:57 PM |
| Szlosek Thomas A | EVP & CFO | Nov 16, 2022 | Buy | $20.71 | 12,500 | 258,850 | 35,668 | Nov 17, 2022, 04:42 PM |
| Stubblefield Michael | CEO | Nov 16, 2022 | Buy | $20.95 | 15,000 | 314,250 | 429,500 | Nov 17, 2022, 04:42 PM |
| Brophy Gerard | EVP, Biopharma Production | May 20, 2022 | Sale | $31.27 | 19,603 | 612,986 | 96,935 | May 23, 2022, 04:46 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | May 23, 2022 | Sale | $31.61 | 39,000 | 1,232,790 | 126,764 | May 23, 2022, 04:45 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | May 17, 2022 | Option Exercise | $31.33 | 2,210 | 69,239 | 165,764 | May 19, 2022, 04:15 PM |
| Eck Steven W | SVP & Chief Accounting Officer | May 17, 2022 | Option Exercise | $31.33 | 573 | 17,952 | 17,747 | May 19, 2022, 04:14 PM |
| Miller Justin | EVP & General Counsel | May 17, 2022 | Option Exercise | $31.33 | 12,935 | 405,254 | 79,312 | May 19, 2022, 04:14 PM |
| Szlosek Thomas A | EVP & CFO | May 17, 2022 | Option Exercise | $31.33 | 23,261 | 728,767 | 140,260 | May 19, 2022, 04:14 PM |
| Couturier Christophe | EVP, AMEA | May 17, 2022 | Option Exercise | $31.33 | 16,212 | 507,922 | 98,348 | May 19, 2022, 04:14 PM |
| Stubblefield Michael | President and CEO | May 17, 2022 | Option Exercise | $31.33 | 108,700 | 3,405,571 | 1,189,841 | May 19, 2022, 04:13 PM |
| Brophy Gerard | EVP, Biopharma Production | May 17, 2022 | Option Exercise | $31.33 | 19,683 | 616,668 | 116,538 | May 19, 2022, 04:13 PM |
| Couturier Christophe | EVP, AMEA | Apr 05, 2022 | Option Exercise | $31.62 | 568 | 17,960 | 114,560 | Apr 07, 2022, 05:47 PM |
| Brophy Gerard | EVP, Biopharma Production | Mar 01, 2022 | Sale | $34.47 | 2,027 | 69,871 | 136,221 | Mar 02, 2022, 05:07 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | Feb 25, 2022 | Option Exercise | $35.39 | 216 | 7,644 | 167,974 | Feb 25, 2022, 09:36 PM |
| Szlosek Thomas A | EVP & CFO | Feb 25, 2022 | Option Exercise | $35.39 | 2,043 | 72,302 | 252,746 | Feb 25, 2022, 09:34 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 25, 2022 | Option Exercise | $35.39 | 2,043 | 72,302 | 138,248 | Feb 25, 2022, 09:32 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 23, 2022 | Sale | $33.79 | 3,059 | 103,364 | 125,181 | Feb 25, 2022, 09:32 PM |
| Couturier Christophe | EVP, AMEA | Feb 25, 2022 | Option Exercise | $35.39 | 467 | 16,527 | 115,128 | Feb 25, 2022, 09:27 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 25, 2022 | Option Exercise | $35.39 | 518 | 18,332 | 18,320 | Feb 25, 2022, 09:25 PM |
| Henson Meghan | EVP, Chief HR Officer | Feb 25, 2022 | Option Exercise | $35.39 | 931 | 32,948 | 31,405 | Feb 25, 2022, 09:22 PM |
| Lewis Sheri | EVP, Global Ops & Supply Chain | Feb 25, 2022 | Option Exercise | $35.39 | 1,137 | 40,238 | 71,448 | Feb 25, 2022, 09:19 PM |
| Miller Justin | EVP & General Counsel | Feb 25, 2022 | Option Exercise | $35.39 | 583 | 20,632 | 92,247 | Feb 25, 2022, 09:16 PM |
| Stubblefield Michael | CEO | Feb 25, 2022 | Option Exercise | $35.39 | 7,866 | 278,378 | 1,313,041 | Feb 25, 2022, 09:11 PM |
| Miller Justin | EVP & General Counsel | Feb 20, 2022 | Option Exercise | $34.00 | 1,328 | 45,152 | 86,030 | Feb 22, 2022, 05:29 PM |
| Szlosek Thomas A | EVP & CFO | Feb 20, 2022 | Option Exercise | $34.00 | 4,040 | 137,360 | 238,168 | Feb 22, 2022, 05:29 PM |
| Couturier Christophe | EVP, AMEA | Feb 20, 2022 | Option Exercise | $34.00 | 1,267 | 43,078 | 109,551 | Feb 22, 2022, 05:28 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 20, 2022 | Option Exercise | $34.00 | 3,072 | 104,448 | 128,240 | Feb 22, 2022, 05:27 PM |
| Stubblefield Michael | President and CEO | Feb 20, 2022 | Option Exercise | $34.00 | 10,959 | 372,606 | 1,251,022 | Feb 22, 2022, 05:27 PM |
| Vanderhaegen Frederic | EVP, Europe | Feb 20, 2022 | Option Exercise | $28.69 | 398 | 11,419 | 153,080 | Feb 22, 2022, 05:26 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 20, 2022 | Option Exercise | $34.00 | 448 | 15,232 | 13,700 | Feb 22, 2022, 05:26 PM |
| Murray Mark Christopher | EVP, Biomaterials & AT | Jan 13, 2022 | Option Exercise | $37.50 | 918 | 34,425 | 18,680 | Jan 18, 2022, 05:12 PM |
| Henson Meghan | EVP, Chief HR Officer | Dec 31, 2021 | Option Exercise | $42.14 | 1,877 | 79,097 | 24,025 | Jan 03, 2022, 04:24 PM |
| Lewis Sheri | EVP, Global Ops & Supply Chain | Dec 31, 2021 | Option Exercise | $42.14 | 4,093 | 172,479 | 62,763 | Jan 03, 2022, 04:21 PM |
| Couturier Christophe | EVP, AMEA | Dec 27, 2021 | Option Exercise | $23.21 | 10,184 | 236,371 | 120,681 | Dec 28, 2021, 04:56 PM |
| Couturier Christophe | EVP, AMEA | Dec 27, 2021 | Sale | $41.63 | 10,184 | 423,960 | 110,497 | Dec 28, 2021, 04:56 PM |
| Couturier Christophe | EVP, AMEA | Dec 22, 2021 | Option Exercise | $23.21 | 28,125 | 652,781 | 138,622 | Dec 23, 2021, 04:28 PM |
| Couturier Christophe | EVP, AMEA | Dec 21, 2021 | Option Exercise | $23.21 | 38,309 | 889,152 | 148,806 | Dec 23, 2021, 04:28 PM |
| Couturier Christophe | EVP, AMEA | Dec 22, 2021 | Sale | $41.53 | 28,125 | 1,168,031 | 110,497 | Dec 23, 2021, 04:28 PM |
| Couturier Christophe | EVP, AMEA | Dec 21, 2021 | Sale | $41.00 | 38,309 | 1,570,669 | 110,497 | Dec 23, 2021, 04:28 PM |
| Couturier Christophe | EVP, AMEA | Dec 08, 2021 | Option Exercise | $17.67 | 5,828 | 102,981 | 116,325 | Dec 10, 2021, 05:00 PM |
| Couturier Christophe | EVP, AMEA | Dec 09, 2021 | Option Exercise | $17.67 | 7,859 | 138,869 | 118,356 | Dec 10, 2021, 05:00 PM |
| Couturier Christophe | EVP, AMEA | Dec 09, 2021 | Sale | $40.24 | 7,859 | 316,246 | 110,497 | Dec 10, 2021, 05:00 PM |
| Couturier Christophe | EVP, AMEA | Dec 08, 2021 | Sale | $40.00 | 5,828 | 233,120 | 110,497 | Dec 10, 2021, 05:00 PM |
| GUPTA RAJIV | Director | Dec 01, 2021 | Sale | $39.30 | 100,000 | 3,930,000 | 879,347 | Dec 03, 2021, 08:31 AM |
| Vanderhaegen Frederic | EVP, Europe | Nov 12, 2021 | Option Exercise | $23.20 | 80,000 | 1,856,000 | 234,495 | Nov 15, 2021, 05:33 PM |
| Vanderhaegen Frederic | EVP, Europe | Nov 12, 2021 | Sale | $38.25 | 80,000 | 3,060,000 | 154,495 | Nov 15, 2021, 05:33 PM |
| Vanderhaegen Frederic | EVP, Europe | Nov 11, 2021 | Sale | $38.41 | 60,804 | 2,335,482 | 154,495 | Nov 15, 2021, 05:33 PM |
| GUPTA RAJIV | Director | Nov 01, 2021 | Sale | $40.31 | 100,000 | 4,031,000 | 979,347 | Nov 02, 2021, 08:24 PM |
| GUPTA RAJIV | Director | Oct 01, 2021 | Sale | $39.94 | 100,000 | 3,994,000 | 1,079,347 | Oct 04, 2021, 05:28 PM |
| Stubblefield Michael | President and CEO | Sep 20, 2021 | Sale | $42.37 | 141,300 | 5,986,881 | 1,261,981 | Sep 22, 2021, 05:16 PM |
| GUPTA RAJIV | Director | Sep 01, 2021 | Sale | $39.45 | 100,000 | 3,945,000 | 1,179,347 | Sep 02, 2021, 05:55 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Aug 26, 2021 | Sale | $40.08 | 17,383 | 696,711 | 14,148 | Aug 27, 2021, 04:18 PM |
| GUPTA RAJIV | Director | Aug 20, 2021 | Sale | $38.81 | 100,000 | 3,881,000 | 1,279,347 | Aug 23, 2021, 05:26 PM |
| Natauri Jo | Director | Jul 12, 2021 | Buy | $36.33 | 300 | 10,900 | 557,656 | Aug 13, 2021, 05:10 PM |
| Brophy Gerard | EVP, Biopharma Production | Jul 30, 2021 | Option Exercise | $23.20 | 81,125 | 1,882,100 | 230,504 | Aug 02, 2021, 04:42 PM |
| Brophy Gerard | EVP, Biopharma Production | Jul 30, 2021 | Sale | $37.24 | 81,125 | 3,021,095 | 149,379 | Aug 02, 2021, 04:42 PM |
| Bramwell James | EVP, Strategic Partners | Jul 20, 2021 | Sale | $37.00 | 6,112 | 226,144 | 79,899 | Jul 21, 2021, 05:04 PM |
| Bramwell James | EVP, Strategic Partners | Jul 09, 2021 | Sale | $35.61 | 18,331 | 652,828 | 98,232 | Jul 13, 2021, 05:32 PM |
| GUPTA RAJIV | Director | Jun 25, 2021 | Sale | $35.32 | 68,605 | 2,423,129 | 1,379,347 | Jun 28, 2021, 04:55 PM |
| Ohri Devashish | EVP, IMEA | May 24, 2021 | Option Exercise | $17.67 | 9,124 | 161,221 | 148,219 | May 25, 2021, 05:08 PM |
| Ohri Devashish | EVP, IMEA | May 24, 2021 | Sale | $31.75 | 9,124 | 289,687 | 139,095 | May 25, 2021, 05:08 PM |
| Miller Justin | EVP & General Counsel | May 20, 2021 | Sale | $31.12 | 18,488 | 575,347 | 86,536 | May 21, 2021, 04:55 PM |
| Couturier Christophe | EVP, AMEA | May 20, 2021 | Sale | $31.13 | 25,010 | 778,561 | 138,173 | May 21, 2021, 04:55 PM |
| Brophy Gerard | EVP, Biopharma Production | May 17, 2021 | Option Exercise | $30.90 | 19,683 | 608,205 | 168,982 | May 19, 2021, 05:17 PM |
| Vanderhaegen Frederic | EVP, Europe | May 17, 2021 | Option Exercise | $30.90 | 2,210 | 68,289 | 214,384 | May 19, 2021, 05:16 PM |
| Bramwell James | EVP, Strategic Partners | May 17, 2021 | Option Exercise | $30.90 | 14,324 | 442,612 | 103,812 | May 19, 2021, 05:16 PM |
| Szlosek Thomas A | EVP & CFO | May 17, 2021 | Option Exercise | $30.90 | 23,261 | 718,765 | 249,394 | May 19, 2021, 05:16 PM |
| Wondrasch Michael | EVP & CIO | May 17, 2021 | Option Exercise | $30.90 | 13,655 | 421,939 | 131,783 | May 19, 2021, 05:15 PM |
| Natauri Jo | Director | May 11, 2021 | Option Exercise | $30.86 | 92,661 | 2,859,519 | 92,661 | May 13, 2021, 05:47 PM |
| Natauri Jo | Director | May 11, 2021 | Option Exercise | $30.86 | 24,729,495 | 763,152,231 | 175,625 | May 13, 2021, 05:47 PM |
| Natauri Jo | Director | May 11, 2021 | Sale | $30.68 | 2,626,771 | 80,589,335 | 24,807,518 | May 13, 2021, 05:47 PM |
| Ohri Devashish | EVP, IMEA | Apr 12, 2021 | Option Exercise | $1.60 | 100,160 | 160,256 | 256,048 | Apr 13, 2021, 06:03 PM |
| Ohri Devashish | EVP, IMEA | Apr 12, 2021 | Sale | $32.37 | 100,160 | 3,242,179 | 155,888 | Apr 13, 2021, 06:03 PM |
| Vanderhaegen Frederic | EVP, Europe | Apr 12, 2021 | Sale | $31.80 | 27,075 | 860,997 | 233,669 | Apr 13, 2021, 06:03 PM |
| Bramwell James | EVP, Strategic Partners | Apr 12, 2021 | Sale | $32.00 | 2,505 | 80,160 | 118,136 | Apr 13, 2021, 06:02 PM |
| Miller Justin | EVP & General Counsel | Apr 12, 2021 | Option Exercise | $23.21 | 100,000 | 2,321,000 | 218,679 | Apr 13, 2021, 06:02 PM |
| Miller Justin | EVP & General Counsel | Apr 12, 2021 | Sale | $33.17 | 102,895 | 3,412,916 | 118,679 | Apr 13, 2021, 06:02 PM |
| Vanderhaegen Frederic | EVP, Europe | Mar 09, 2021 | Sale | $28.21 | 10,000 | 282,100 | 243,669 | Mar 10, 2021, 05:08 PM |
| Wondrasch Michael | EVP & CIO | Mar 02, 2021 | Sale | $28.71 | 3,036 | 87,164 | 145,438 | Mar 03, 2021, 05:11 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 24, 2021 | Option Exercise | $27.94 | 2,577 | 72,001 | 25,955 | Feb 26, 2021, 06:44 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 24, 2021 | Sale | $27.93 | 3,059 | 85,438 | 172,384 | Feb 26, 2021, 06:34 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 22, 2021 | Option Exercise | $28.69 | 3,072 | 88,136 | 175,443 | Feb 23, 2021, 05:51 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 22, 2021 | Option Exercise | $17.67 | 19,769 | 349,318 | 195,212 | Feb 23, 2021, 05:51 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 22, 2021 | Sale | $28.62 | 19,769 | 565,789 | 175,443 | Feb 23, 2021, 05:51 PM |
| Couturier Christophe | EVP, Services | Feb 22, 2021 | Option Exercise | $28.69 | 1,313 | 37,670 | 162,408 | Feb 23, 2021, 05:50 PM |
| Wondrasch Michael | EVP & CIO | Feb 22, 2021 | Option Exercise | $28.69 | 1,209 | 34,686 | 140,334 | Feb 23, 2021, 05:47 PM |
| Miller Justin | EVP & General Counsel | Feb 22, 2021 | Option Exercise | $28.69 | 1,350 | 38,732 | 113,434 | Feb 23, 2021, 05:46 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 22, 2021 | Option Exercise | $28.69 | 449 | 12,882 | 19,982 | Feb 23, 2021, 05:44 PM |
| Vanderhaegen Frederic | EVP, Europe | Feb 22, 2021 | Option Exercise | $28.69 | 398 | 11,419 | 237,388 | Feb 23, 2021, 05:43 PM |
| Stubblefield Michael | President and CEO | Feb 22, 2021 | Option Exercise | $28.69 | 10,141 | 290,945 | 1,437,122 | Feb 23, 2021, 05:42 PM |
| Bramwell James | EVP, Strategic Partners | Feb 22, 2021 | Option Exercise | $28.69 | 1,216 | 34,887 | 115,214 | Feb 23, 2021, 05:41 PM |
| Ohri Devashish | EVP, IMEA | Feb 22, 2021 | Option Exercise | $28.69 | 1,210 | 34,715 | 150,461 | Feb 23, 2021, 05:39 PM |
| Szlosek Thomas A | EVP & CFO | Feb 22, 2021 | Option Exercise | $28.69 | 2,980 | 85,496 | 256,374 | Feb 23, 2021, 05:38 PM |
| Wondrasch Michael | EVP & CIO | Feb 05, 2021 | Option Exercise | $23.20 | 40,000 | 928,000 | 181,543 | Feb 08, 2021, 06:23 PM |
| Wondrasch Michael | EVP & CIO | Feb 05, 2021 | Sale | $29.77 | 49,468 | 1,472,662 | 141,543 | Feb 08, 2021, 06:23 PM |
| Murray Mark Christopher | EVP, Biomaterials & AT | Jan 13, 2021 | Option Exercise | $29.20 | 918 | 26,806 | 11,458 | Jan 15, 2021, 05:05 PM |
| Bramwell James | EVP, Strategic Partners | Jan 11, 2021 | Sale | $30.00 | 2,505 | 75,150 | 116,430 | Jan 13, 2021, 05:43 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 11, 2021 | Option Exercise | $23.20 | 378,580 | 8,783,056 | 394,847 | Jan 13, 2021, 05:41 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 11, 2021 | Sale | $30.06 | 378,580 | 11,381,197 | 178,515 | Jan 13, 2021, 05:41 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 06, 2021 | Sale | $27.24 | 11,509 | 313,505 | 178,515 | Jan 08, 2021, 07:31 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 02, 2021 | Option Exercise | $28.15 | 6,559 | 184,636 | 190,024 | Jan 06, 2021, 09:06 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 04, 2021 | Option Exercise | $18.45 | 59,418 | 1,096,262 | 249,442 | Jan 06, 2021, 09:06 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 04, 2021 | Sale | $27.84 | 59,418 | 1,654,197 | 190,024 | Jan 06, 2021, 09:06 PM |
| Szlosek Thomas A | EVP & CFO | Jan 02, 2021 | Option Exercise | $28.15 | 8,135 | 229,000 | 257,999 | Jan 06, 2021, 09:00 PM |
| Vanderhaegen Frederic | EVP, Europe | Jan 02, 2021 | Option Exercise | $28.15 | 1,017 | 28,629 | 236,414 | Jan 06, 2021, 08:56 PM |
| Wondrasch Michael | EVP & CIO | Jan 02, 2021 | Option Exercise | $28.15 | 4,083 | 114,936 | 149,974 | Jan 06, 2021, 08:53 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Dec 31, 2020 | Option Exercise | $28.15 | 3,052 | 85,914 | 20,431 | Jan 06, 2021, 08:50 PM |
| Bramwell James | EVP, Strategic Partners | Dec 21, 2020 | Sale | $27.14 | 10,020 | 271,943 | 117,768 | Dec 23, 2020, 05:10 PM |
| Shaw Christi | Director | Dec 11, 2020 | Sale | $26.68 | 14,286 | 381,150 | 11,319 | Dec 15, 2020, 07:16 PM |
| Stubblefield Michael | President and CEO | Dec 07, 2020 | Option Exercise | $1.60 | 210,369 | 336,590 | 1,945,717 | Dec 08, 2020, 07:09 PM |
| Stubblefield Michael | President and CEO | Dec 04, 2020 | Option Exercise | $1.60 | 880,601 | 1,408,962 | 2,147,536 | Dec 08, 2020, 07:09 PM |
| Stubblefield Michael | President and CEO | Dec 07, 2020 | Sale | $27.45 | 98,452 | 2,702,507 | 1,847,265 | Dec 08, 2020, 07:09 PM |
| Stubblefield Michael | President and CEO | Dec 04, 2020 | Sale | $27.08 | 412,188 | 11,162,051 | 1,735,348 | Dec 08, 2020, 07:09 PM |
| Natauri Jo | Director | Jun 25, 2020 | Buy | $16.84 | 151 | 2,543 | 58,881,889 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 19, 2020 | Buy | $17.95 | 2 | 36 | 58,881,469 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jul 01, 2020 | Buy | $16.99 | 1,491 | 25,332 | 58,885,713 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 18, 2020 | Buy | $17.51 | 6,798 | 119,033 | 58,881,461 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 12, 2020 | Buy | $16.98 | 300 | 5,094 | 58,881,101 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 23, 2020 | Buy | $17.75 | 300 | 5,325 | 58,881,711 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 30, 2020 | Buy | $17.09 | 4,053 | 69,270 | 58,885,836 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 22, 2020 | Buy | $17.38 | 29 | 504 | 58,881,462 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 26, 2020 | Buy | $16.82 | 20 | 336 | 58,881,228 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 11, 2020 | Buy | $16.92 | 2,055 | 34,771 | 58,883,032 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jul 01, 2020 | Sale | $17.05 | 25,410 | 433,156 | 58,875,713 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 25, 2020 | Sale | $16.84 | 151 | 2,543 | 58,881,738 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 23, 2020 | Sale | $17.75 | 300 | 5,325 | 58,881,411 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 30, 2020 | Sale | $17.09 | 4,053 | 69,266 | 58,884,852 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 18, 2020 | Sale | $17.51 | 6,798 | 119,033 | 58,874,663 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 12, 2020 | Sale | $16.98 | 300 | 5,094 | 58,880,801 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 22, 2020 | Sale | $17.38 | 29 | 504 | 58,881,433 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 26, 2020 | Sale | $16.82 | 20 | 336 | 58,881,208 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 11, 2020 | Sale | $16.92 | 2,055 | 34,771 | 58,880,977 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 19, 2020 | Sale | $17.95 | 2 | 36 | 58,881,467 | Nov 12, 2020, 07:35 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 25, 2020 | Buy | $16.84 | 151 | 2,543 | 58,881,889 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 11, 2020 | Buy | $16.92 | 2,055 | 34,771 | 58,883,032 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 19, 2020 | Buy | $17.95 | 2 | 36 | 58,881,469 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jul 01, 2020 | Buy | $16.99 | 1,491 | 25,332 | 58,885,713 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 18, 2020 | Buy | $17.51 | 6,798 | 119,033 | 58,881,461 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 23, 2020 | Buy | $17.75 | 300 | 5,325 | 58,881,711 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 30, 2020 | Buy | $17.09 | 4,053 | 69,270 | 58,885,836 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 12, 2020 | Buy | $16.98 | 300 | 5,094 | 58,881,101 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 22, 2020 | Buy | $17.38 | 29 | 504 | 58,881,462 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 26, 2020 | Buy | $16.82 | 20 | 336 | 58,881,228 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jul 01, 2020 | Sale | $17.05 | 25,410 | 433,156 | 58,875,713 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 25, 2020 | Sale | $16.84 | 151 | 2,543 | 58,881,738 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 23, 2020 | Sale | $17.75 | 300 | 5,325 | 58,881,411 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 30, 2020 | Sale | $17.09 | 4,053 | 69,266 | 58,884,852 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 18, 2020 | Sale | $17.51 | 6,798 | 119,033 | 58,874,663 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 22, 2020 | Sale | $17.38 | 29 | 504 | 58,881,433 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 26, 2020 | Sale | $16.82 | 20 | 336 | 58,881,208 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 12, 2020 | Sale | $16.98 | 300 | 5,094 | 58,880,801 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 11, 2020 | Sale | $16.92 | 2,055 | 34,771 | 58,880,977 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 19, 2020 | Sale | $17.95 | 2 | 36 | 58,881,467 | Nov 12, 2020, 07:31 PM |
| New Mountain Investments III, LLC | 10% Owner | Nov 10, 2020 | Sale | $24.81 | 36,016,093 | 893,490,828 | 28,000,000 | Nov 10, 2020, 09:24 PM |
| Ohri Devashish | EVP, IMEA | Oct 05, 2020 | Option Exercise | $1.60 | 103,440 | 165,504 | 201,671 | Oct 07, 2020, 08:23 PM |
| Ohri Devashish | EVP, IMEA | Oct 05, 2020 | Sale | $23.42 | 103,440 | 2,422,343 | 151,671 | Oct 07, 2020, 08:23 PM |
| Ohri Devashish | EVP, IMEA | Sep 16, 2020 | Option Exercise | $1.60 | 35,000 | 56,000 | 186,671 | Sep 17, 2020, 04:39 PM |
| Ohri Devashish | EVP, IMEA | Sep 16, 2020 | Sale | $23.02 | 35,000 | 805,700 | 151,671 | Sep 17, 2020, 04:39 PM |
| Miller Justin | EVP & General Counsel | Sep 08, 2020 | Sale | $21.17 | 22,887 | 484,518 | 113,507 | Sep 09, 2020, 04:43 PM |
| Natauri Jo | Director | Aug 21, 2020 | Sale | $19.51 | 15,397,005 | 300,341,682 | 43,483,708 | Aug 25, 2020, 08:46 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Aug 21, 2020 | Sale | $19.51 | 15,397,005 | 300,341,682 | 43,483,708 | Aug 25, 2020, 08:40 PM |
| New Mountain Investments III, LLC | 10% Owner | Aug 21, 2020 | Sale | $19.51 | 25,575,472 | 498,887,951 | 64,016,093 | Aug 25, 2020, 05:08 PM |
| GUPTA RAJIV | Director | Aug 19, 2020 | Option Exercise | $1.60 | 1,147,970 | 1,836,752 | 1,856,716 | Aug 19, 2020, 02:06 PM |
| Ohri Devashish | EVP, IMEA | Jul 30, 2020 | Option Exercise | $1.60 | 35,000 | 56,000 | 186,671 | Aug 03, 2020, 05:45 PM |
| Ohri Devashish | EVP, IMEA | Jul 30, 2020 | Sale | $21.37 | 35,000 | 747,950 | 151,671 | Aug 03, 2020, 05:45 PM |
| Ohri Devashish | EVP, IMEA | May 29, 2020 | Option Exercise | $1.60 | 65,000 | 104,000 | 186,671 | Jun 02, 2020, 05:50 PM |
| Ohri Devashish | EVP, IMEA | May 29, 2020 | Sale | $18.84 | 65,000 | 1,224,550 | 151,671 | Jun 02, 2020, 05:50 PM |
| New Mountain Investments III, LLC | 10% Owner | May 26, 2020 | Sale | $15.90 | 20,886,424 | 332,192,314 | 89,591,565 | May 28, 2020, 06:01 PM |
| Natauri Jo | Director | May 26, 2020 | Sale | $15.90 | 13,726,411 | 218,249,930 | 58,881,710 | May 28, 2020, 05:35 PM |
| Natauri Jo | Director | Jun 13, 2019 | Option Exercise | $0.00 | 1,133,920 | 2,268 | 72,605,349 | May 28, 2020, 05:35 PM |
| Connolly Thomas | Director | May 26, 2020 | Sale | $15.90 | 13,726,411 | 218,249,930 | 58,881,710 | May 28, 2020, 05:31 PM |
| Connolly Thomas | Director | Jun 13, 2019 | Option Exercise | $0.00 | 1,133,920 | 2,268 | 72,605,349 | May 28, 2020, 05:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | May 26, 2020 | Sale | $15.90 | 13,726,411 | 218,249,930 | 58,881,710 | May 28, 2020, 05:26 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 13, 2019 | Option Exercise | $0.00 | 1,133,920 | 2,268 | 72,605,349 | May 28, 2020, 05:26 PM |
| Wondrasch Michael | EVP & CIO | May 22, 2020 | Sale | $17.82 | 22,987 | 409,628 | 154,087 | May 27, 2020, 04:26 PM |
| Brophy Gerard | EVP, Biopharma Production | May 20, 2020 | Sale | $17.36 | 25,495 | 442,593 | 196,583 | May 22, 2020, 04:22 PM |
| Szlosek Thomas A | EVP & CFO | May 17, 2020 | Option Exercise | $17.86 | 21,287 | 380,186 | 266,134 | May 19, 2020, 06:58 PM |
| Wondrasch Michael | EVP & CIO | May 17, 2020 | Option Exercise | $17.86 | 9,155 | 163,508 | 177,044 | May 19, 2020, 06:57 PM |
| Brophy Gerard | EVP, Biopharma Production | May 17, 2020 | Option Exercise | $17.86 | 13,790 | 246,289 | 222,078 | May 19, 2020, 06:55 PM |
| Couturier Christophe | EVP, Services | May 17, 2020 | Option Exercise | $17.86 | 11,189 | 199,836 | 162,932 | May 19, 2020, 06:53 PM |
| Vanderhaegen Frederic | EVP, Europe | May 17, 2020 | Option Exercise | $17.86 | 2,210 | 39,471 | 237,431 | May 19, 2020, 06:52 PM |
| Miller Justin | EVP & General Counsel | May 17, 2020 | Option Exercise | $17.86 | 9,155 | 163,508 | 136,394 | May 19, 2020, 06:50 PM |
| Ohri Devashish | EVP, IMEA | May 17, 2020 | Option Exercise | $17.86 | 16,791 | 299,887 | 151,671 | May 19, 2020, 06:48 PM |
| McAllister Eric | EVP, CHRO | May 17, 2020 | Option Exercise | $17.86 | 9,155 | 163,508 | 197,899 | May 19, 2020, 06:47 PM |
| Stubblefield Michael | CEO | May 17, 2020 | Option Exercise | $17.86 | 108,700 | 1,941,382 | 1,266,935 | May 19, 2020, 06:45 PM |
| Bramwell James | EVP, Strategic Partners | May 17, 2020 | Option Exercise | $17.86 | 12,102 | 216,142 | 127,788 | May 19, 2020, 06:44 PM |
| Eck Steven W | SVP & Chief Accounting Officer | May 17, 2020 | Option Exercise | $17.86 | 573 | 10,234 | 23,483 | May 19, 2020, 06:42 PM |
| McAllister Eric | EVP, CHRO | Apr 24, 2020 | Option Exercise | $14.04 | 8,975 | 126,009 | 207,054 | May 12, 2020, 04:34 PM |
| Stubblefield Michael | CEO | Mar 12, 2020 | Option Exercise | $1.60 | 200,000 | 320,000 | 1,375,635 | Mar 13, 2020, 04:32 PM |
| GUPTA RAJIV | Director | Mar 10, 2020 | Option Exercise | $1.60 | 143,000 | 228,800 | 708,746 | Mar 12, 2020, 04:25 PM |
| Ohri Devashish | EVP, IMEA | Feb 18, 2020 | Option Exercise | $1.60 | 20,000 | 32,000 | 177,143 | Feb 20, 2020, 05:32 PM |
| Ohri Devashish | EVP, IMEA | Feb 18, 2020 | Sale | $17.54 | 20,000 | 350,800 | 157,143 | Feb 20, 2020, 05:32 PM |
| New Mountain Investments III, LLC | 10% Owner | May 21, 2019 | Sale | $14.00 | 100 | 1,400 | 110,477,989 | May 23, 2019, 07:31 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Couturier Christophe | EVP, AMEA | 04/05/2024 | 14,720 |
| Eck Steven W | SVP & Chief Accounting Officer | 03/08/2024 | 94,447 |
| Bramwell James | EVP Sales, Customer Excellence | 02/29/2024 | 120,393 |
| Couturier Christophe | EVP, AMEA | 02/29/2024 | 320,705 |
| Bramwell James | EVP Sales, Customer Excellence | 02/27/2024 | 151,911 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/25/2024 | 12,297 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/24/2024 | 10,665 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/23/2024 | 10,276 |
| Stubblefield Michael | President & CEO | 02/22/2024 | 1,012,542 |
| Stubblefield Michael | President & CEO | 02/25/2024 | 187,130 |
| Stubblefield Michael | President & CEO | 02/24/2024 | 233,638 |
| Stubblefield Michael | President & CEO | 02/23/2024 | 180,726 |
| Sahin Kitty | EVP, Strategy&Corp Development | 02/24/2024 | 25,787 |
| Hankamer Brittany | EVP, Chief HR Officer | 02/23/2024 | 10,251 |
| Hankamer Brittany | EVP, Chief HR Officer | 02/25/2024 | 8,985 |
| Hankamer Brittany | EVP, Chief HR Officer | 02/24/2024 | 10,641 |
| Bramwell James | EVP Sales, Customer Excellence | 02/25/2024 | 12,443 |
| Bramwell James | EVP Sales, Customer Excellence | 02/24/2024 | 47,604 |
| Bramwell James | EVP Sales, Customer Excellence | 02/23/2024 | 13,855 |
| Bramwell James | EVP Sales, Customer Excellence | 02/22/2024 | 69,885 |
| Couturier Christophe | EVP, AMEA | 02/25/2024 | 11,371 |
| Couturier Christophe | EVP, AMEA | 02/24/2024 | 15,779 |
| Couturier Christophe | EVP, AMEA | 02/23/2024 | 10,130 |
| Couturier Christophe | EVP, AMEA | 02/22/2024 | 63,295 |
| Hankamer Brittany | EVP, Chief HR Officer | 02/20/2024 | 6,950 |
| Bramwell James | EVP Sales, Customer Excellence | 02/20/2024 | 29,245 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/20/2024 | 10,462 |
| Stubblefield Michael | President & CEO | 02/20/2024 | 233,550 |
| Couturier Christophe | EVP, AMEA | 02/20/2024 | 33,478 |
| Sahin Kitty | EVP, Strategy&Corp Development | 07/18/2023 | 82,590 |
| Eck Steven W | SVP & Chief Accounting Officer | 09/07/2023 | 156,389 |
| Hankamer Brittany | EVP, Chief HR Officer | 09/05/2023 | 6,705 |
| Vanderhaegen Frederic | EVP, Americas and Europe | 08/25/2023 | 536,750 |
| Couturier Christophe | EVP, AMEA | 05/17/2023 | 318,518 |
| Miller Justin | EVP & General Counsel | 05/17/2023 | 252,466 |
| Stubblefield Michael | President & CEO | 05/17/2023 | 2,153,736 |
| Brophy Gerard | EVP, Biopharma Production | 05/17/2023 | 399,171 |
| Eck Steven W | SVP & Chief Accounting Officer | 05/17/2023 | 11,215 |
| Vanderhaegen Frederic | EVP, Americas and Europe | 05/17/2023 | 44,819 |
| Szlosek Thomas A | EVP & CFO | 05/17/2023 | 471,733 |
| Bramwell James | EVP, Strategic Partners | 05/17/2023 | 383,637 |
| Couturier Christophe | EVP, AMEA | 04/11/2023 | 31,728 |
| Couturier Christophe | EVP, AMEA | 04/05/2023 | 11,847 |
| Brophy Gerard | EVP, Biopharma Production | 03/03/2023 | 97,850 |
| Brophy Gerard | EVP, Biopharma Production | 02/27/2023 | 76,475 |
| Couturier Christophe | EVP, AMEA | 02/28/2023 | 56,520 |
| Brophy Gerard | EVP, Biopharma Production | 02/25/2023 | 50,225 |
| Brophy Gerard | EVP, Biopharma Production | 02/23/2023 | 46,549 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/23/2023 | 10,352 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/25/2023 | 12,433 |
| Szlosek Thomas A | EVP & CFO | 02/25/2023 | 50,225 |
| Szlosek Thomas A | EVP & CFO | 02/23/2023 | 51,196 |
| Vanderhaegen Frederic | EVP, Americas and Europe | 02/23/2023 | 5,238 |
| Vanderhaegen Frederic | EVP, Americas and Europe | 02/25/2023 | 7,361 |
| Couturier Christophe | EVP, AMEA | 02/25/2023 | 11,498 |
| Couturier Christophe | EVP, AMEA | 02/23/2023 | 10,229 |
| Couturier Christophe | EVP, AMEA | 02/23/2023 | 74,611 |
| Henson Meghan | EVP, Chief HR Officer | 02/25/2023 | 19,696 |
| Henson Meghan | EVP, Chief HR Officer | 02/23/2023 | 20,065 |
| Bramwell James | EVP, Americas | 02/23/2023 | 13,992 |
| Bramwell James | EVP, Americas | 02/25/2023 | 12,581 |
| Miller Justin | EVP & General Counsel | 02/25/2023 | 13,787 |
| Miller Justin | EVP & General Counsel | 02/23/2023 | 11,508 |
| Lewis Sheri | EVP, Global Ops & Supply Chain | 02/25/2023 | 32,991 |
| Lewis Sheri | EVP, Global Ops & Supply Chain | 02/23/2023 | 23,852 |
| Stubblefield Michael | President & CEO | 02/23/2023 | 182,507 |
| Stubblefield Michael | President & CEO | 02/25/2023 | 189,205 |
| Szlosek Thomas A | EVP & CFO | 02/20/2023 | 104,369 |
| Couturier Christophe | EVP, AMEA | 02/20/2023 | 28,638 |
| Couturier Christophe | EVP, AMEA | 02/22/2023 | 462,139 |
| Miller Justin | EVP & General Counsel | 02/20/2023 | 28,638 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/20/2023 | 10,675 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 02/20/2023 | 9,767 |
| Brophy Gerard | EVP, Biopharma Production | 02/20/2023 | 75,387 |
| Bramwell James | EVP, Americas | 02/20/2023 | 26,160 |
| Stubblefield Michael | President & CEO | 02/20/2023 | 368,738 |
| Wondrasch Michael | EVP & CIO | 02/20/2023 | 33,276 |
| Couturier Christophe | EVP, AMEA | 01/31/2023 | 183,026 |
| Stubblefield Michael | CEO | 01/31/2023 | 2,178,246 |
| Brophy Gerard | EVP, Biopharma Production | 01/31/2023 | 363,782 |
| Brophy Gerard | EVP, Biopharma Production | 02/02/2023 | 284,155 |
| Miller Justin | EVP & General Counsel | 01/31/2023 | 189,814 |
| Szlosek Thomas A | EVP & CFO | 01/31/2023 | 578,069 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 01/31/2023 | 60,108 |
| Henson Meghan | EVP, Chief HR Officer | 12/31/2022 | 37,751 |
| Lewis Sheri | EVP, Global Ops & Supply Chain | 12/31/2022 | 128,122 |
| Brophy Gerard | EVP, Biopharma Production | 01/02/2023 | 141,872 |
| Szlosek Thomas A | EVP & CFO | 01/02/2023 | 175,321 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 01/02/2023 | 21,449 |
| Szlosek Thomas A | EVP & CFO | 11/16/2022 | 258,850 |
| Stubblefield Michael | CEO | 11/16/2022 | 314,250 |
| Brophy Gerard | EVP, Biopharma Production | 05/20/2022 | 612,986 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 05/23/2022 | 1,232,790 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 05/17/2022 | 69,239 |
| Eck Steven W | SVP & Chief Accounting Officer | 05/17/2022 | 17,952 |
| Miller Justin | EVP & General Counsel | 05/17/2022 | 405,254 |
| Szlosek Thomas A | EVP & CFO | 05/17/2022 | 728,767 |
| Couturier Christophe | EVP, AMEA | 05/17/2022 | 507,922 |
| Stubblefield Michael | President and CEO | 05/17/2022 | 3,405,571 |
| Brophy Gerard | EVP, Biopharma Production | 05/17/2022 | 616,668 |
| Couturier Christophe | EVP, AMEA | 04/05/2022 | 17,960 |
| Brophy Gerard | EVP, Biopharma Production | 03/01/2022 | 69,871 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 02/25/2022 | 7,644 |
| Szlosek Thomas A | EVP & CFO | 02/25/2022 | 72,302 |
| Brophy Gerard | EVP, Biopharma Production | 02/25/2022 | 72,302 |
| Brophy Gerard | EVP, Biopharma Production | 02/23/2022 | 103,364 |
| Couturier Christophe | EVP, AMEA | 02/25/2022 | 16,527 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/25/2022 | 18,332 |
| Henson Meghan | EVP, Chief HR Officer | 02/25/2022 | 32,948 |
| Lewis Sheri | EVP, Global Ops & Supply Chain | 02/25/2022 | 40,238 |
| Miller Justin | EVP & General Counsel | 02/25/2022 | 20,632 |
| Stubblefield Michael | CEO | 02/25/2022 | 278,378 |
| Miller Justin | EVP & General Counsel | 02/20/2022 | 45,152 |
| Szlosek Thomas A | EVP & CFO | 02/20/2022 | 137,360 |
| Couturier Christophe | EVP, AMEA | 02/20/2022 | 43,078 |
| Brophy Gerard | EVP, Biopharma Production | 02/20/2022 | 104,448 |
| Stubblefield Michael | President and CEO | 02/20/2022 | 372,606 |
| Vanderhaegen Frederic | EVP, Europe | 02/20/2022 | 11,419 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/20/2022 | 15,232 |
| Murray Mark Christopher | EVP, Biomaterials & AT | 01/13/2022 | 34,425 |
| Henson Meghan | EVP, Chief HR Officer | 12/31/2021 | 79,097 |
| Lewis Sheri | EVP, Global Ops & Supply Chain | 12/31/2021 | 172,479 |
| Couturier Christophe | EVP, AMEA | 12/27/2021 | 236,371 |
| Couturier Christophe | EVP, AMEA | 12/27/2021 | 423,960 |
| Couturier Christophe | EVP, AMEA | 12/22/2021 | 652,781 |
| Couturier Christophe | EVP, AMEA | 12/21/2021 | 889,152 |
| Couturier Christophe | EVP, AMEA | 12/22/2021 | 1,168,031 |
| Couturier Christophe | EVP, AMEA | 12/21/2021 | 1,570,669 |
| Couturier Christophe | EVP, AMEA | 12/08/2021 | 102,981 |
| Couturier Christophe | EVP, AMEA | 12/09/2021 | 138,869 |
| Couturier Christophe | EVP, AMEA | 12/09/2021 | 316,246 |
| Couturier Christophe | EVP, AMEA | 12/08/2021 | 233,120 |
| GUPTA RAJIV | Director | 12/01/2021 | 3,930,000 |
| Vanderhaegen Frederic | EVP, Europe | 11/12/2021 | 1,856,000 |
| Vanderhaegen Frederic | EVP, Europe | 11/12/2021 | 3,060,000 |
| Vanderhaegen Frederic | EVP, Europe | 11/11/2021 | 2,335,482 |
| GUPTA RAJIV | Director | 11/01/2021 | 4,031,000 |
| GUPTA RAJIV | Director | 10/01/2021 | 3,994,000 |
| Stubblefield Michael | President and CEO | 09/20/2021 | 5,986,881 |
| GUPTA RAJIV | Director | 09/01/2021 | 3,945,000 |
| Eck Steven W | SVP & Chief Accounting Officer | 08/26/2021 | 696,711 |
| GUPTA RAJIV | Director | 08/20/2021 | 3,881,000 |
| Natauri Jo | Director | 07/12/2021 | 10,900 |
| Brophy Gerard | EVP, Biopharma Production | 07/30/2021 | 1,882,100 |
| Brophy Gerard | EVP, Biopharma Production | 07/30/2021 | 3,021,095 |
| Bramwell James | EVP, Strategic Partners | 07/20/2021 | 226,144 |
| Bramwell James | EVP, Strategic Partners | 07/09/2021 | 652,828 |
| GUPTA RAJIV | Director | 06/25/2021 | 2,423,129 |
| Ohri Devashish | EVP, IMEA | 05/24/2021 | 161,221 |
| Ohri Devashish | EVP, IMEA | 05/24/2021 | 289,687 |
| Miller Justin | EVP & General Counsel | 05/20/2021 | 575,347 |
| Couturier Christophe | EVP, AMEA | 05/20/2021 | 778,561 |
| Brophy Gerard | EVP, Biopharma Production | 05/17/2021 | 608,205 |
| Vanderhaegen Frederic | EVP, Europe | 05/17/2021 | 68,289 |
| Bramwell James | EVP, Strategic Partners | 05/17/2021 | 442,612 |
| Szlosek Thomas A | EVP & CFO | 05/17/2021 | 718,765 |
| Wondrasch Michael | EVP & CIO | 05/17/2021 | 421,939 |
| Natauri Jo | Director | 05/11/2021 | 2,859,519 |
| Natauri Jo | Director | 05/11/2021 | 763,152,231 |
| Natauri Jo | Director | 05/11/2021 | 80,589,335 |
| Ohri Devashish | EVP, IMEA | 04/12/2021 | 160,256 |
| Ohri Devashish | EVP, IMEA | 04/12/2021 | 3,242,179 |
| Vanderhaegen Frederic | EVP, Europe | 04/12/2021 | 860,997 |
| Bramwell James | EVP, Strategic Partners | 04/12/2021 | 80,160 |
| Miller Justin | EVP & General Counsel | 04/12/2021 | 2,321,000 |
| Miller Justin | EVP & General Counsel | 04/12/2021 | 3,412,916 |
| Vanderhaegen Frederic | EVP, Europe | 03/09/2021 | 282,100 |
| Wondrasch Michael | EVP & CIO | 03/02/2021 | 87,164 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/24/2021 | 72,001 |
| Brophy Gerard | EVP, Biopharma Production | 02/24/2021 | 85,438 |
| Brophy Gerard | EVP, Biopharma Production | 02/22/2021 | 88,136 |
| Brophy Gerard | EVP, Biopharma Production | 02/22/2021 | 349,318 |
| Brophy Gerard | EVP, Biopharma Production | 02/22/2021 | 565,789 |
| Couturier Christophe | EVP, Services | 02/22/2021 | 37,670 |
| Wondrasch Michael | EVP & CIO | 02/22/2021 | 34,686 |
| Miller Justin | EVP & General Counsel | 02/22/2021 | 38,732 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/22/2021 | 12,882 |
| Vanderhaegen Frederic | EVP, Europe | 02/22/2021 | 11,419 |
| Stubblefield Michael | President and CEO | 02/22/2021 | 290,945 |
| Bramwell James | EVP, Strategic Partners | 02/22/2021 | 34,887 |
| Ohri Devashish | EVP, IMEA | 02/22/2021 | 34,715 |
| Szlosek Thomas A | EVP & CFO | 02/22/2021 | 85,496 |
| Wondrasch Michael | EVP & CIO | 02/05/2021 | 928,000 |
| Wondrasch Michael | EVP & CIO | 02/05/2021 | 1,472,662 |
| Murray Mark Christopher | EVP, Biomaterials & AT | 01/13/2021 | 26,806 |
| Bramwell James | EVP, Strategic Partners | 01/11/2021 | 75,150 |
| Brophy Gerard | EVP, Biopharma Production | 01/11/2021 | 8,783,056 |
| Brophy Gerard | EVP, Biopharma Production | 01/11/2021 | 11,381,197 |
| Brophy Gerard | EVP, Biopharma Production | 01/06/2021 | 313,505 |
| Brophy Gerard | EVP, Biopharma Production | 01/02/2021 | 184,636 |
| Brophy Gerard | EVP, Biopharma Production | 01/04/2021 | 1,096,262 |
| Brophy Gerard | EVP, Biopharma Production | 01/04/2021 | 1,654,197 |
| Szlosek Thomas A | EVP & CFO | 01/02/2021 | 229,000 |
| Vanderhaegen Frederic | EVP, Europe | 01/02/2021 | 28,629 |
| Wondrasch Michael | EVP & CIO | 01/02/2021 | 114,936 |
| Eck Steven W | SVP & Chief Accounting Officer | 12/31/2020 | 85,914 |
| Bramwell James | EVP, Strategic Partners | 12/21/2020 | 271,943 |
| Shaw Christi | Director | 12/11/2020 | 381,150 |
| Stubblefield Michael | President and CEO | 12/07/2020 | 336,590 |
| Stubblefield Michael | President and CEO | 12/04/2020 | 1,408,962 |
| Stubblefield Michael | President and CEO | 12/07/2020 | 2,702,507 |
| Stubblefield Michael | President and CEO | 12/04/2020 | 11,162,051 |
| Natauri Jo | Director | 06/25/2020 | 2,543 |
| Natauri Jo | Director | 06/19/2020 | 36 |
| Natauri Jo | Director | 07/01/2020 | 25,332 |
| Natauri Jo | Director | 06/18/2020 | 119,033 |
| Natauri Jo | Director | 06/12/2020 | 5,094 |
| Natauri Jo | Director | 06/23/2020 | 5,325 |
| Natauri Jo | Director | 06/30/2020 | 69,270 |
| Natauri Jo | Director | 06/22/2020 | 504 |
| Natauri Jo | Director | 06/26/2020 | 336 |
| Natauri Jo | Director | 06/11/2020 | 34,771 |
| Natauri Jo | Director | 07/01/2020 | 433,156 |
| Natauri Jo | Director | 06/25/2020 | 2,543 |
| Natauri Jo | Director | 06/23/2020 | 5,325 |
| Natauri Jo | Director | 06/30/2020 | 69,266 |
| Natauri Jo | Director | 06/18/2020 | 119,033 |
| Natauri Jo | Director | 06/12/2020 | 5,094 |
| Natauri Jo | Director | 06/22/2020 | 504 |
| Natauri Jo | Director | 06/26/2020 | 336 |
| Natauri Jo | Director | 06/11/2020 | 34,771 |
| Natauri Jo | Director | 06/19/2020 | 36 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/25/2020 | 2,543 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/11/2020 | 34,771 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/19/2020 | 36 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 07/01/2020 | 25,332 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/18/2020 | 119,033 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/23/2020 | 5,325 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/30/2020 | 69,270 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/12/2020 | 5,094 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/22/2020 | 504 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/26/2020 | 336 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 07/01/2020 | 433,156 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/25/2020 | 2,543 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/23/2020 | 5,325 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/30/2020 | 69,266 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/18/2020 | 119,033 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/22/2020 | 504 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/26/2020 | 336 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/12/2020 | 5,094 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/11/2020 | 34,771 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/19/2020 | 36 |
| New Mountain Investments III, LLC | 10% Owner | 11/10/2020 | 893,490,828 |
| Ohri Devashish | EVP, IMEA | 10/05/2020 | 165,504 |
| Ohri Devashish | EVP, IMEA | 10/05/2020 | 2,422,343 |
| Ohri Devashish | EVP, IMEA | 09/16/2020 | 56,000 |
| Ohri Devashish | EVP, IMEA | 09/16/2020 | 805,700 |
| Miller Justin | EVP & General Counsel | 09/08/2020 | 484,518 |
| Natauri Jo | Director | 08/21/2020 | 300,341,682 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 08/21/2020 | 300,341,682 |
| New Mountain Investments III, LLC | 10% Owner | 08/21/2020 | 498,887,951 |
| GUPTA RAJIV | Director | 08/19/2020 | 1,836,752 |
| Ohri Devashish | EVP, IMEA | 07/30/2020 | 56,000 |
| Ohri Devashish | EVP, IMEA | 07/30/2020 | 747,950 |
| Ohri Devashish | EVP, IMEA | 05/29/2020 | 104,000 |
| Ohri Devashish | EVP, IMEA | 05/29/2020 | 1,224,550 |
| New Mountain Investments III, LLC | 10% Owner | 05/26/2020 | 332,192,314 |
| Natauri Jo | Director | 05/26/2020 | 218,249,930 |
| Natauri Jo | Director | 06/13/2019 | 2,268 |
| Connolly Thomas | Director | 05/26/2020 | 218,249,930 |
| Connolly Thomas | Director | 06/13/2019 | 2,268 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 05/26/2020 | 218,249,930 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/13/2019 | 2,268 |
| Wondrasch Michael | EVP & CIO | 05/22/2020 | 409,628 |
| Brophy Gerard | EVP, Biopharma Production | 05/20/2020 | 442,593 |
| Szlosek Thomas A | EVP & CFO | 05/17/2020 | 380,186 |
| Wondrasch Michael | EVP & CIO | 05/17/2020 | 163,508 |
| Brophy Gerard | EVP, Biopharma Production | 05/17/2020 | 246,289 |
| Couturier Christophe | EVP, Services | 05/17/2020 | 199,836 |
| Vanderhaegen Frederic | EVP, Europe | 05/17/2020 | 39,471 |
| Miller Justin | EVP & General Counsel | 05/17/2020 | 163,508 |
| Ohri Devashish | EVP, IMEA | 05/17/2020 | 299,887 |
| McAllister Eric | EVP, CHRO | 05/17/2020 | 163,508 |
| Stubblefield Michael | CEO | 05/17/2020 | 1,941,382 |
| Bramwell James | EVP, Strategic Partners | 05/17/2020 | 216,142 |
| Eck Steven W | SVP & Chief Accounting Officer | 05/17/2020 | 10,234 |
| McAllister Eric | EVP, CHRO | 04/24/2020 | 126,009 |
| Stubblefield Michael | CEO | 03/12/2020 | 320,000 |
| GUPTA RAJIV | Director | 03/10/2020 | 228,800 |
| Ohri Devashish | EVP, IMEA | 02/18/2020 | 32,000 |
| Ohri Devashish | EVP, IMEA | 02/18/2020 | 350,800 |
| New Mountain Investments III, LLC | 10% Owner | 05/21/2019 | 1,400 |
Load More Insider Transactions
FUNDS WITH A POSITION IN AVANTOR INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| DODGE & COX | 61,196,331 | 0.89% | 360.4% | Value |
| BLACKROCK INC. | 45,846,483 | 0.03% | 1.38% | Other |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | 24,364,915 | 1.96% | 17.59% | Value |
| GEODE CAPITAL MANAGEMENT, LLC | 9,853,506 | 0.02% | 4.12% | Other |
| PARNASSUS INVESTMENTS, LLC | 6,938,004 | 0.35% | No change | Growth At A Reasonable Price |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,400,100 | 0.07% | 75.01% | Other |
| SOROS FUND MANAGEMENT LLC | 800,000 | 0.24% | New | Other |
| AQR CAPITAL MANAGEMENT LLC | 455,010 | 0.02% | -55.13% | Other |
| GABELLI FUNDS LLC | 425,224 | 0.07% | No change | Event Driven, Growth, Activists |
| OLSTEIN CAPITAL MANAGEMENT, L.P. | 315,000 | 1.21% | 2.94% | Value |
| BALYASNY ASSET MANAGEMENT L.P. | 153,373 | 0.00658% | -96.3% | Event Driven |
| D. E. SHAW & CO., INC. | 140,599 | 0.0028% | 423.98% | Other |
| SAND GROVE CAPITAL MANAGEMENT LLP | 88,000 | 0.53% | New | Value |
| CANDRIAM S.C.A. | 44,233 | 0.00697% | No change | Other |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 38,250 | 0.04% | No change | Growth At A Reasonable Price |
| GOTHAM ASSET MANAGEMENT, LLC | 17,096 | 0.00724% | -49.86% | Other |
| FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 15,882 | 0.00086% | No change | Value |
CHANGE IN SHARES OUTSTANDING FOR AVANTOR INC.
STOCK BUYBACKS FOR AVANTOR INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.12%
1Q
06/30/2023
0.59%
2Q
03/31/2023
0.18%
3Q
12/31/2022
0.43%
4Q
09/30/2022
0%
5Q
06/30/2022
-0.13%
6Q
03/31/2022
-0.29%
7Q
12/31/2021
9.67%
8Q
09/30/2021
13.58%
9Q
06/30/2021
14.92%
10Q
03/31/2021
15.31%
11Q
12/31/2020
15.90%
12Q
09/30/2020
17.69%
13Q
06/30/2020
16.70%
14Q
03/31/2020
16.86%
15Q
12/31/2019
69.32%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AVANTOR INC.
LOADING...